See more : Great Elm Capital Group, Inc. (GECCL) Income Statement Analysis – Financial Results
Complete financial analysis of SenesTech, Inc. (SNES) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SenesTech, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Ritco Logistics Limited (RITCO.BO) Income Statement Analysis – Financial Results
- PT Wira Global Solusi Tbk (WGSH.JK) Income Statement Analysis – Financial Results
- IRIS Business Services Limited (IRIS.BO) Income Statement Analysis – Financial Results
- Sammakorn Public Company Limited (SAMCO.BK) Income Statement Analysis – Financial Results
- eBay Inc. (EBAY) Income Statement Analysis – Financial Results
SenesTech, Inc. (SNES)
About SenesTech, Inc.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19M | 1.02M | 576.00K | 258.00K | 143.00K | 297.00K | 52.00K | 318.00K | 241.00K | 199.00K |
| Cost of Revenue | 654.00K | 555.00K | 356.00K | 281.00K | 101.00K | 241.00K | 45.00K | 196.00K | 0.00 | 0.00 |
| Gross Profit | 539.00K | 464.00K | 220.00K | -23.00K | 42.00K | 56.00K | 7.00K | 122.00K | 241.00K | 199.00K |
| Gross Profit Ratio | 45.18% | 45.53% | 38.19% | -8.91% | 29.37% | 18.86% | 13.46% | 38.36% | 100.00% | 100.00% |
| Research & Development | 1.23M | 1.86M | 1.95M | 1.49M | 1.91M | 2.40M | 3.19M | 2.71M | 7.22M | 3.20M |
| General & Administrative | 6.70M | 7.59M | 7.22M | 6.44M | 0.00 | 9.53M | 9.13M | 8.13M | 8.67M | 2.70M |
| Selling & Marketing | 317.00K | 631.00K | 584.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.02M | 8.28M | 7.22M | 6.44M | 8.42M | 9.53M | 9.13M | 8.13M | 8.67M | 2.70M |
| Other Expenses | 27.00K | -26.00K | -24.00K | -24.00K | 266.00K | 21.00K | 87.00K | -31.00K | -678.00K | 31.00K |
| Operating Expenses | 8.27M | 10.14M | 9.15M | 7.91M | 10.33M | 11.94M | 12.32M | 10.83M | 15.89M | 5.90M |
| Cost & Expenses | 8.93M | 10.69M | 9.51M | 8.19M | 10.43M | 12.18M | 12.37M | 10.83M | 15.89M | 5.90M |
| Interest Income | 26.00K | 7.00K | 4.00K | 3.00K | 45.00K | 25.00K | 29.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 4.00K | 2.00K | 11.00K | 28.00K | 42.00K | 74.00K | 86.00K | 87.00K | 855.00K | 632.00K |
| Depreciation & Amortization | 135.00K | 183.00K | 303.00K | 288.00K | 413.00K | 447.00K | 391.00K | 196.00K | 182.00K | 125.00K |
| EBITDA | -7.57M | -9.51M | -7.95M | -7.62M | -9.56M | -11.39M | -11.81M | -10.51M | -17.14M | -6.44M |
| EBITDA Ratio | -634.62% | -951.23% | -1,550.35% | -3,065.50% | -6,687.41% | -3,834.01% | -22,709.62% | -3,255.03% | -6,697.51% | -2,784.42% |
| Operating Income | -7.73M | -9.67M | -8.93M | -7.93M | -10.29M | -11.88M | -12.32M | -10.52M | -15.65M | -5.70M |
| Operating Income Ratio | -648.11% | -949.36% | -1,551.04% | -3,074.81% | -7,193.71% | -4,000.00% | -23,684.62% | -3,306.92% | -6,491.70% | -2,862.81% |
| Total Other Income/Expenses | 22.00K | -21.00K | 666.00K | -4.00K | 269.00K | -28.00K | 30.00K | -279.00K | -2.53M | -1.50M |
| Income Before Tax | -7.71M | -9.70M | -8.27M | -7.94M | -10.02M | -11.91M | -12.29M | -10.80M | -18.17M | -7.20M |
| Income Before Tax Ratio | -646.27% | -951.42% | -1,435.42% | -3,076.36% | -7,005.59% | -4,009.43% | -23,626.92% | -3,394.65% | -7,540.66% | -3,618.09% |
| Income Tax Expense | 0.00 | 19.00K | -292.00K | -239.00K | 308.00K | 46.00K | 173.00K | 56.00K | 177.00K | 663.00K |
| Net Income | -7.71M | -9.71M | -7.98M | -7.70M | -10.33M | -11.91M | -12.29M | -10.80M | -18.17M | -7.20M |
| Net Income Ratio | -646.27% | -953.29% | -1,384.72% | -2,983.72% | -7,220.98% | -4,009.43% | -23,626.92% | -3,394.65% | -7,540.66% | -3,618.09% |
| EPS | -11.51 | -186.39 | -171.04 | -614.56 | -1.90K | -245.50 | -450.00 | -672.84 | -1.09K | -403.93 |
| EPS Diluted | -115.10 | -186.39 | -171.04 | -614.56 | -1.90K | -245.50 | -450.00 | -672.84 | -1.09K | -403.93 |
| Weighted Avg Shares Out | 669.85K | 52.12K | 46.63K | 12.53K | 5.43K | 48.51K | 27.30K | 16.04K | 16.65K | 17.83K |
| Weighted Avg Shares Out (Dil) | 66.99K | 52.12K | 46.63K | 12.53K | 5.43K | 48.51K | 27.30K | 16.04K | 16.65K | 17.83K |
SenesTech Signs Wilco Distributing for Evolve™ and ContraPest® Distribution in Agriculture and Professional Rodent Pest Management Market
PHOENIX , March 26, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces a signed distribution agreement with Wilco Distributors Inc., a distributor of pest management...
SenesTech to Present at the Emerging Growth Conference on March 6, 2024
Webcasted presentation to take place at 1:10pm ET PHOENIX , March 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) today announced that the Company will be participating in the Emerging Growth Conference on March 6, 2024. Management will deliver a...
SenesTech, Inc. (SNES) Q4 2023 Earnings Call Transcript
SenesTech, Inc. (SNES) Q4 2023 Earnings Call Transcript
SenesTech Announces 2023 Financial Results
YTD 2024 total revenue up more than 80% compared to YTD 2023 driven by orders for Evolve™ soft bait PHOENIX , Feb. 21, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the rodent fertility control experts and inventors of...
SenesTech (SNES) Expands in the Netherlands With Q-chem Deal
SenesTech's (SNES) collaboration with Q-chem strategically aligns with the Netherlands' Integrated Pest Control program.
SenesTech to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Wednesday, February 21, 2024
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , Feb. 15, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its fourth quarter and fiscal year 2023, ended...
SenesTech Announces Exclusive Distribution Agreement for Evolve™ Soft Bait in The Netherlands
PHOENIX , Feb. 15, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces entry into a distribution agreement with Q-chem, a pest control product supplier in The...
SenesTech Approved as Vendor for All Ace Hardware Stores
PHOENIX , Feb. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces that the Company has been accepted as a vendor for the full Ace...
SenesTech Announces Exclusive Distribution Agreement for Evolve™ Soft Bait in Australia and New Zealand
PHOENIX , Feb. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces entry into a Distribution Agreement with Evicom, an environmental management firm based in Australia...
SenesTech Announces Exclusive Distribution Agreement and Initial Order for Evolve™ Soft Bait in Singapore
Further Expansion in the Region Is Contemplated in the Agreement PHOENIX, Feb. 5, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces entry into a Distribution...
Source: https://incomestatements.info
Category: Stock Reports